Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
  1. Homepage
  2. Equities
  3. India
  4. NSE India Stock Exchange
  5. Sun Pharmaceutical Industries Ltd.
  6. News
  7. Summary
    SUNPHARMA   INE044A01036

SUN PHARMACEUTICAL INDUSTRIES LTD.

(SUNPHARMA)
  Report
Delayed NSE India Stock Exchange  -  06:25 2022-12-08 am EST
980.80 INR   -3.63%
06:10aIndian Equities Bounce Back at the Close, Lifted by Public Sector Bank Stocks
MT
12:29aSun Pharma gets FDA import warning for India plant, shares drop
RE
12:28aUS FDA Places Sun Pharmaceutical's Halol Facility in India Under Import Alert; Shares Down 3%
MT
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisionsFunds 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

Sun Pharmaceutical Completes Acquisition of Uractiv Portfolio from Fiterman Pharma in Romania

09/28/2022 | 03:59am EST


ę MT Newswires 2022
All news about SUN PHARMACEUTICAL INDUSTRIES LTD.
06:10aIndian Equities Bounce Back at the Close, Lifted by Public Sector Bank Stocks
MT
12:29aSun Pharma gets FDA import warning for India plant, shares drop
RE
12:28aUS FDA Places Sun Pharmaceutical's Halol Facility in India Under Import Alert; Shares D..
MT
12/07India's Sun Pharma says Halol facility listed under FDA import alert
RE
11/25Sun Pharmaceutical's Psoriatic Arthritis Drug Up for Strong Sales Once Available
MT
11/21Sun Pharmaceutical Industries Limited - SEZABY approved by US FDA for the treatment of ..
AQ
11/17Sun Pharma Advanced, Sun Pharma Get US FDA Nod for Neonatal Seizures Treatment Drug
MT
11/17Sun Pharmaceutical Industries Limited and Sun Pharma Advanced Research Company Limited ..
CI
11/09Sun Pharma Unit and SPARC Sign Licensing Deal for Neonatal Seizure Drug in US
MT
11/09Sun Pharma and SPARC Enter into License Agreement for Commercialization of Phenobarbita..
CI
More news
Analyst Recommendations on SUN PHARMACEUTICAL INDUSTRIES LTD.
More recommendations
Financials
Sales 2023 439 B 5 333 M 5 333 M
Net income 2023 85 562 M 1 039 M 1 039 M
Net cash 2023 123 B 1 495 M 1 495 M
P/E ratio 2023 28,5x
Yield 2023 0,77%
Capitalization 2 442 B 29 664 M 29 664 M
EV / Sales 2023 5,28x
EV / Sales 2024 4,65x
Nbr of Employees 38 000
Free-Float 44,4%
Chart SUN PHARMACEUTICAL INDUSTRIES LTD.
Duration : Period :
Sun Pharmaceutical Industries Ltd. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends SUN PHARMACEUTICAL INDUSTRIES LTD.
Short TermMid-TermLong Term
TrendsNeutralBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 36
Last Close Price 1 017,75 INR
Average target price 1 145,03 INR
Spread / Average Target 12,5%
EPS Revisions
Managers and Directors
Dilip Shantilal Shanghvi Managing Director & Executive Director
C. S. Muralidharan Chief Financial Officer
Davinder Singh Executive Vice President-Global Operations
Ashok I. Bhuta Compliance Officer & Senior GM-Secretarial
Anoop Deshpande Secretary & Compliance Officer